Conclusion
This current research yields data that contribute
to the growing body of knowledge concerning the role of alexithymia in the etiology of psychosomatic and other disorders of
affect regulation. The data support the heuristic value of the alexithymia construct in conceptualizing and explaining some
of the deficits involved in disorders characterized by affect dysregulation. The results of this current research are consistent
with findings of earlier studies while at odds with the results of others.
Zeitlin and McNally (1993) found greater association
between alexithymia and PD than with OCD. Parker, Taylor, Bagby and Acklin (1993) found higher rates of alexithymia in those
with PD compared to those with simple phobia. And Joukamaa and Lepola (1994) found more alexithymia in those with PD than
in a healthy control group. The results of this current research are consistent with these studies in finding greater correlation
between alexithymia and PD than with other disorders.
On the other hand, Cox, Swinson, Shulman and
Bourdeau (1995) found a non-significant difference in alexithymia between a PD sample and a social phobia sample. Fukunishi,
Kikuchi, Wogan and Takubo (1997) found a non-significant difference between PD and social phobia samples. And Bankier, Aigner
and Bach (2001) found lower alexithymia scores for a PD sample compared to somatoform, obsessive-compulsive and depression
samples.
While research results may be inconsistent, or
even contradictory, the current research results are consistent with the author’s experience in treating those with
PD compared to other mental health disorders. The degree of affective unawareness in psychosomatic disorders such as PD is
commensurate with the degree of somatization and tendency for catastrophic explanations of somatic experiences. The F1 subfactor
on the TAS-20 isolates this trait and identifies the difficulty in distinguishing between emotions and related physiological
sensations. It would be expected that there would be significant elevation on F1 by those with PD compared to controls, and
this current research confirms this. Some of the inconsistent findings by earlier studies are related to a lack of subfactorial
analysis.
The most prominent implications of this current
research derive from two sources. First is the significant involvement of the TAS-20 F1 deficits in PD for both genders. And
second is the considerable gender difference in the prevalence of alexithymia. Given the extent of difference between genders
in the manifestation of alexithymic traits, it is all the more noteworthy that the only area of congruence between the genders
is in the elevation of F1 scores in PD. The implication is that the F1 deficits – difficulty identifying emotions and
differentiating them from their related physiological sequelae – are the alexithymic component most involved in PD.
The somatization process inherent in this component underscores Nemiah’s (1984) conceptualization of PD as a psychosomatic
disorder. The Krystal model (1988) as well as the Lane and Schwartz model (1987) suggest the origin of the somatization in
PD to be the arrest at or regression to an earlier, non-verbal and somatized level of affect development. The implications
for treatment then would appear obvious – that affects need to become more well identified and verbalized to become
more cognitive and less somatic.
Directions for
Future Research
The results of this current research provide
additional empirical support for the significance of certain alexithymic traits in the etiology of PD. These current research
hypotheses seem to be appropriate directions for future research given the large body of literature supportive of the theory
outlined in the literature review. It would be of value for future research to address some of the limitations of this current
research that are noted earlier. It would be beneficial for future research to be conducted with larger sample groups, possibly
controlling for age and gender using a narrower age range or single gender studies.
Given the multi-faceted nature of the alexithymia
construct, future studies might include additional self-report measures or observer-rating instruments designed to isolate
each of the alexithymic traits to provide more information as to which traits are most prominent to PD. Observer-ratings could
also address the inherent problem of the accuracy of self-reported data. Valuable future research might involve the use of
pre and post testing of specific alexithymic traits to obtain information as to the interconnectedness of traits and whether
they respond in tandem or independently to treatment interventions. Additionally, pre and post testing might demonstrate mutability
of alexithymic traits, and thereby influence the state or trait controversy regarding the nature of alexithymia.
Closing Statement
Each is liable to panic, which is exactly, the terror of ignorance surrendered
to the imagination. Knowledge is the encourager, knowledge that takes fear out of the heart, knowledge and use, which is knowledge
in practice. They can conquer who believe they can. It is he who has done the deed once who does not shrink from attempting
again.
- Ralph Waldo Emerson (1803-1882)
This current research offers validation of the above quotations premise, that ignorance provides opportunity for the
imagination to induce fear while knowledge can quell it. The cognitive and affective deficits of alexithymia constitute ignorance
– or rather the lack of self-knowledge – that allows the imagination to generate panic attacks. This research
provides support for the hypothesis that the aspect of alexithymia most responsible for chronic panic attacks is the limited
capacity for identifying emotions and the tendency to confuse them with physical sensations. The cognitive therapy modality
strives to increase self knowledge – thereby reduce alexithymic traits – and has demonstrated the greatest success
of any modality in reducing the frequency and intensity of the panic attacks of PD. Cognitive therapy aims to facilitate progression
in the epigenetic model of affect development, upward from early levels of alexithymic traits to higher levels of desomatized,
verbalized affects. Ultimately, the goal of treatment is the facilitation of the successful completion of normal developmental
epigenesis – from alexithymia to lexithymia.